Generative AI for Drug Discovery: A GPT-2 and LSTM Based Models for Designing EGFR Inhibitors
Omar Dasser, Othman Filali Benaceur, Salma Fadel
This study uses fine-tuned GPT-2 and LSTM models to generate EGFR inhibitors, finding that LSTM produces more valid and potent molecules.
bioRxiv · Oct 19, 2024 · PreprintBioinformatics